Class 4 drug alert: Advanz Pharma Zapain 30mg/500mg tablets (codeine phosphate/paracetamol)

Source:
Medicines and Healthcare products Regulatory Agency - MHRA
Publisher:
Medicines and Healthcare products Regulatory Agency
Publication date:
14 January 2020

Abstract

Advanz Pharma has informed the MHRA of a discrepancy on the product packaging for Zapain 30mg/500mg Tablets. The discrepancy relates to 'capsules' printed at the top right of the packs in error, instead of tablets. Healthcare professionals are advised to exercise caution.